Amyloid duration is associated with preclinical cognitive decline and tau PET
Open accessPublished version of a preprint
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: This study applies a novel algorithm to longitudinal amyloid positron emission tomography (PET) imaging to identify age-heterogeneous amyloid trajectory groups, estimate the age and duration (chronicity) of amyloid positivity, and investigate chronicity in relation to cognitive decline and tau burden. METHODS: = 171) to identify and model amyloid trajectory groups, which were combined with Bayes theorem to estimate age and chronicity of amyloid positivity. Relationships between chronicity, cognition, clinical progression, and tau PET (MK-6240) were investigated using regression models. RESULTS: Chronicity explained more heterogeneity in amyloid burden than age and binary amyloid status. Chronicity was associated with faster cognitive decline, increased risk of abnormal cognition, and higher entorhinal tau. DISCUSSION: Amyloid chronicity provides unique information about cognitive decline and neurofibrillary tangle development and may be useful to investigate preclinical Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Burnham, K. P., Anderson, D. R., & Huyvaert, K. P. (2011) · Behavioral Ecology and Sociobiology · doi:10.1007/s00265-010-1029-6 · Cited by 4,104
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Analyzing developmental trajectories: A semiparametric, group-based approach.
Nagin, D. S. (1999) · Psychological Methods · doi:10.1037/1082-989x.4.2.139 · Cited by 2,346
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Research works printed but not linked: 29
- 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
- Clark LR, 2018, Age‐accelerated cognitive decline in asymptomatic adults with CSF β‐amyloid, Neurology, 90, e1306, 10.1212/WNL.0000000000005291 · DOI · Paper page
- 10.1016/j.jalz.2015.12.009 · DOI · Paper page
- Desikan RS, 2012, Amyloid‐β–associated clinical decline occurs only in the presence of elevated p‐tau, Arch Neurol, 69, 709, 10.1001/archneurol.2011.3354 · DOI · Paper page
- 10.1016/j.neuroimage.2016.04.001 · DOI · Paper page
- 10.3389/fnins.2017.00281 · DOI · Paper page
- Whittington A, 2018, Spatiotemporal distribution of β‐amyloid in Alzheimer disease is the result of heterogeneous regional carrying capacities, J Nucl Med, 59, 822, 10.2967/jnumed.117.194720 · DOI · Paper page
- 10.1177/0049124101029003005 · DOI · Paper page
- 10.2967/jnumed.115.171678 · DOI · Paper page
- Betthauser TJ, 2019, In vivo characterization and quantification of neurofibrillary tau PET radioligand 18F‐MK‐6240 in humans from Alzheimer disease dementia to young controls, J Nucl Med, 60, 93, 10.2967/jnumed.118.209650 · DOI · Paper page
- Johnson SC, 2018, The Wisconsin registry for Alzheimer's prevention: a review of findings and current directions, Alzheimers Dement Diagn Assess Dis Monit, 10, 130
- Jonaitis EM, 2019, Measuring longitudinal cognition: individual tests versus composites, Alzheimers Dement Diagn Assess Dis Monit, 11, 74
- Rey A, 1941, L'examen psychologique dans les cas d'encéphalopathie traumatique (Les problems.), Arch Psychol, 28, 215
- Wechsler D, 1987, WMS‐R: Wechsler Memory Scale‐Revised
- Wechsler D, 1997, WAIS‐III: Wechsler Adult Intelligence Scale
- 10.1523/JNEUROSCI.2990-05.2005 · DOI · Paper page
- 10.1016/j.neurobiolaging.2015.05.004 · DOI · Paper page
- 10.3233/JAD-160528 · DOI · Paper page
- 10.1016/j.neurobiolaging.2013.09.028 · DOI · Paper page
- 10.1177/0049124106292364 · DOI · Paper page
- 10.1146/annurev.clinpsy.121208.131413 · DOI · Paper page
- 10.11613/BM.2012.031 · DOI · Paper page
- 10.1017/S1355617718000929 · DOI
- Whittington A, 2016, Spatiotemporal distribution of β‐amyloid in Alzheimer's disease results from heterogeneous regional carrying capacities, J Nucl Med, 57, 346
- 10.1016/j.jalz.2015.08.166 · DOI · Paper page
- 10.1016/j.neuroimage.2012.07.059 · DOI · Paper page
- 10.1001/archneur.65.11.1509 · DOI · Paper page
- Mormino EC, 2008, Episodic memory loss is related to hippocampal‐mediated β‐amyloid deposition in elderly subjects, Brain, 132, 1310, 10.1093/brain/awn320 · DOI · Paper page
- 10.1093/brain/awz378 · DOI · Paper page
Cited by
Mattsson-Carlgren, N., Salvadó, G., Ashton, N. J., Tideman, P., Stomrud, E., Zetterberg, H., Ossenkoppele, R., Betthauser, T. J., Cody, K. A., Jonaitis, E. M., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5272 · Cited by 309
Self-citationPlasma phosphorylated tau 217 in preclinical Alzheimer’s disease
Jonaitis, E. M., Janelidze, S., Cody, K. A., Langhough, R., Du, L., Chin, N. A., Mattsson-Carlgren, N., Hogan, K. J., Christian, B. T., Betthauser, T. J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad057 · Cited by 124
“32 Estimated age of amyloid onset (EAOA) was obtained from observed global PiB DVR using a combination of group-based trajectory modelling and Bayes’ theorem 33 using either the most recent PET scan (for those who were PiB-) or the scan closest to the PiB+ threshold.”
Self-citationDisease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Golde, T. E. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01201-2 · Cited by 119
Predicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
“Tau is closely linked with beta-amyloidosis; with rare exceptions high baseline neocortical tau is only seen in the presence of high amyloid (Johnson et al., 2016; Pontecorvo et al., 2017; Lowe et al., 2018; Ossenkoppele et al., 2018; Jack et al., 2019b; Koscik et al., 2019; Sperling et al., 2019).”
BackgroundPET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102
“Longitudinal follow-up studies suggest that the duration of Aβ existence might be more important than age or binary result in affecting both deteriorating rate and the final status of cognition through elevated entorhinal tau burden (Hanseeuw et al., 2019; Koscik et al., 2020).”
BackgroundAPOE effects on regional tau in preclinical Alzheimer’s disease
Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., Mormino, E. C., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00590-4 · Cited by 80
Characterizing the emergence of amyloid and tau burden in Down syndrome
Zammit, M. D., Betthauser, T. J., McVea, A. K., Laymon, C. M., Tudorascu, D. L., Johnson, S. C., Hartley, S. L., Converse, A. K., Minhas, D. S., Zaman, S. H., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13444 · Cited by 60
Self-citationMirkin, S., & Albensi, B. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1094233 · Cited by 46
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
Levin, J., Vöglein, J., Quiroz, Y. T., Bateman, R. J., Ghisays, V., Lopera, F., McDade, E., Reiman, E., Tariot, P. N., & Morris, J. C. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12624 · Cited by 40
Wisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00084-x · Cited by 37
“29 We also used models that included participant gender and APOE ε 4 status, but these covariates were non-significant and overall model fit (as assessed by adjusted R 2 ) did not change meaningfully, so these models were not subsequently presented.”
Self-citationSchworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00426-5 · Cited by 29
Self-citation
Metadata
- Authors
- Koscik, R. L., Betthauser, T. J., Jonaitis, E. M., Allison, S. L., Clark, L. R., Hermann, B. P., Cody, K. A., Engle, J. W., Barnhart, T. E., Stone, C. K., Chin, N. A., Carlsson, C. M., Asthana, S., Christian, B. T., & Johnson, S. C.
- Venue
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 12
- Issue
- 1
- Pages
- e12007-e12007
- ISSN
- 2352-8729 (ISSN-L)
- OpenAlex
- W3008536213
- Cited by
- 101
- References
- 13
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (vor, 43 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- National Institutes of Health (R01 AG021155 y6‐y13, R01 AG027161 y1‐y11, P50 AG033514 y1‐y11, U54 HD090256 y1‐y4)
- Alzheimer's Association (AARF‐19‐614533, 2019)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.